EVOK EVOKE PHARMA INC Management Changes 8-K Filing 2025 - Director Appointment On February 20, 2025, Evoke Pharma appointed Greg Pyszcymuka as a Class I director, effective immediately, with options to purchase 5,833 shares of common stock as part of his compensation.Get access to all SEC 8-K filings of the EVOKE PHARMA INC